Hormonal and Metabolic Factors Associated With Variations in Insulin Sensitivity in Human Pregnancy

doi:10.2337/dc09-1196

Hormonal and Metabolic Factors Associated With Variations in Insulin Sensitivity in Human Pregnancy

H. David McIntyre, FRACP¹,
Allan M. Chang, PHD¹,
Leonie K. Callaway, PHD²,
David M. Cowley, FRCPA¹,
Alan R. Dyer, PHD³,
Tatjana Radaelli, MD⁴,⁵,
Kristen A. Farrell, MS⁵,
Larraine Huston-Presley, MS⁵,
Saeid B. Amini, PHD, JD⁵,
John P. Kirwan, PHD⁵,
Patrick M. Catalano, MD⁵ and
for the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study Cooperative Research Group*

¹The University of Queensland and Mater Health Services, South Brisbane, Australia;
²The University of Queensland and Royal Brisbane and Women's Hospital, Herston, Australia;
³Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois;
⁴Department of Mother, Child and Neonate “L. Mangiagalli,” IRCCS Ospedale Maggiore Policlinico Mangiagalli and Regina Elena, Milan, Italy;
⁵Department of Reproductive Biology, Case Western Reserve University at Metro Health Medical Center, Cleveland, Ohio.

Corresponding author: Harold David McIntyre, david.mcintyre{at}mater.org.au.

Abstract

OBJECTIVE The objective of this study was to determine maternal hormonal and metabolic factors associated with insulin sensitivity in human pregnancy.

RESEARCH DESIGN AND METHODS This was a prospective observational cross-sectional study of 180 normal pregnant women, using samples collected at the time of a blinded oral glucose tolerance test (OGTT) between 24 and 32 weeks' gestation as an ancillary to the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study. The study was conducted at two public university teaching hospitals, Cleveland, Ohio, and Brisbane, Australia. Fasting maternal serum cholesterol, triglycerides, free fatty acids, insulin, leptin, tumor necrosis factor-α, placental growth hormone (PGH), insulin-like growth factors (IGFs) 1 and 2, and insulin-like growth factor binding proteins (IGFBPs) 1 and 3 were assayed. Correlation and multiple regression analyses were used to determine factors associated with maternal insulin sensitivity (IS) estimated using both OGTT-derived (IS_OGTT) and fasting (using the homeostasis model assessment [HOMA]; IS_HOMA) insulin and glucose concentrations.

RESULTS Insulin sensitivity correlated (r = x and y for IS_OGTT and IS_HOMA, respectively) with fasting maternal serum leptin (−0.44 and −0.52), IGFBP1 (0.42 and 0.39), and triglycerides (−0.31 and −0.27). These factors were significantly associated with insulin sensitivity in multiple regression analyses (adjusted R² 0.44 for IS_OGTT and IS_HOMA). These variables explained more than 40% of the variance in estimates of insulin sensitivity.

CONCLUSIONS Maternal hormonal and metabolic factors related to the placenta, adipose tissue, and the growth hormone axis are associated with the variation in insulin sensitivity seen during normal human pregnancy.

Footnotes

↵*Members of the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study Cooperative Research Group are listed in the Appendix of HAPO Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008;358:1991–2002.
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
- Received June 30, 2009.
- Accepted October 16, 2009.